These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 657827)

  • 1. A study on tissue concentrations of cephradine achieved in patients with peripheral vascular disease.
    Matharu SS; Ramsden CH; Kester RC
    Curr Med Res Opin; 1978; 5(6):427-32. PubMed ID: 657827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetrability of cephazolin into the subcutaneous fat and skeletal muscle of ischaemic lower limbs with atherosclerotic disease.
    Kester RC; Ramsden CH; Matharu SS
    Curr Med Res Opin; 1979; 6(1):44-9. PubMed ID: 378557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue levels of cephradine in ischaemic limbs following a single intravenous injection.
    Bullen BR; Ramsden CH; Kester RC
    Curr Med Res Opin; 1980; 6(9):585-8. PubMed ID: 7408526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroperative cephradine concentrations in the gall bladder wall and bile.
    Bullen BR; Ramsden CH; Kester RC
    Curr Med Res Opin; 1982; 8(1):5-8. PubMed ID: 7105822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement.
    Cain TJ; Jones GT; Woods P
    Int Orthop; 1987; 11(1):61-3. PubMed ID: 3557757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of cefamandole, cefuroxime and cephradine during total hip replacement.
    Davies AJ; Lockley RM; Jones A; el-Safty M; Clothier JC
    J Antimicrob Chemother; 1986 May; 17(5):637-40. PubMed ID: 3722034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of cephradine into heart valves, subcutaneous tissue and muscle of patients undergoing open heart surgery.
    Daschner FD; Langmaack H; Spillner G; Ahmadi A; Schlosser V
    J Antimicrob Chemother; 1979 Nov; 5(6):711-5. PubMed ID: 536355
    [No Abstract]   [Full Text] [Related]  

  • 8. Penetration of cephradine and cefazolin into ulcers of patients suffering from peripheral arterial circulatory insufficiency.
    Rylander M; Mannheimer C; Brorson JE
    Scand J Infect Dis; 1979; 11(4):281-6. PubMed ID: 531521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bone levels after intramuscular administration of cephradine ('Velosef') or flucloxacillin/ampicillin in hip replacement.
    Brooks S; Dent AR
    Pharmatherapeutica; 1984; 3(10):642-9. PubMed ID: 6463064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.
    Cunha BA; Gossling HR; Pasternak HS; Nightingale CH; Quintiliani R
    J Bone Joint Surg Am; 1977 Oct; 59(7):856-9. PubMed ID: 908715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cephradine in open heart serugery. Concentrations of cephradine in pericardial exudate and serum after cardiac surgery (author's transl)].
    Adam D; Krebber HJ; Raff W; Voigt I
    Med Klin; 1977 Oct; 72(43):1808-13. PubMed ID: 927285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human lung tissue and serum concentrations of cefradin (author's transl)].
    Moatti N; Fournial G; Berthoumieu F; Gaillard J
    Pathol Biol (Paris); 1978 Dec; 26(9-10):577-80. PubMed ID: 370751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephradine levels in human aqueous humor.
    Axelrod JL; Kochman RS
    Arch Ophthalmol; 1981 Nov; 99(11):2034-6. PubMed ID: 7295154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tissue levels of cefamandole in severely ischaemic lower limbs using two regimens of dosage.
    Bullen BR; Ramsden CH; Kester RC
    Curr Med Res Opin; 1979; 6(4):244-8. PubMed ID: 527348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cephradine given intravenously with and without probenecid.
    Roberts DH; Kendall MJ; Jack DB; Welling PG
    Br J Clin Pharmacol; 1981 Jun; 11(6):561-4. PubMed ID: 7272172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.
    Pfeffer M; Jackson A; Ximenes J; de Menezes JP
    Antimicrob Agents Chemother; 1977 Feb; 11(2):331-8. PubMed ID: 848940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on cephradine for intravenous injection (author's transl)].
    Sekine O; Usuda Y; Higuchi K; Watanabe M; Yamasaku F
    Jpn J Antibiot; 1976 Nov; 29(11):968-72. PubMed ID: 1003681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
    Philipson A; Stiernstedt G; Ehrnebo M
    Clin Pharmacokinet; 1987 Feb; 12(2):136-44. PubMed ID: 3829560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.